Tear Biomarkers for Migraine

Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Study ID
NCT07690696
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Accepted

Interventions

  • Patients with migraine — DIAGNOSTIC_TEST
    Patients with migraine

Study Details

The goal of this observational monocentric study is to investigate tear and serum biomarkers in patients with migraine compared with healthy controls, and to explore their potential diagnostic, clinical, and predictive value. In addition to the cross-sectional evaluation, a longitudinal subgroup analysis will be conducted to assess biomarker changes over time during treatment with anti- Calcitonin Gene-Related Peptide (anti-CGRP) therapies.

Key Dates

First listed
Jul 8, 2026
Start date
Sep 30, 2026
Status verified
Jun 2026
Primary completion
Sep 29, 2029
Completion
Sep 29, 2029

Study Design

Enrollment
400 participants (estimated)

Arms

  • Arm: Patients with migraine
    Patients with migraine
  • Arm: Healthy controls
    Healthy controls

Primary Outcome Measure

Differences in tear biomarker [ Time Frame: Through the study completion, about 3 years ]

Central Contacts

Find similar trials

Nationwide
Migraine trialsNeurology trials

Related Studies